Fewer needle sticks? study tests larger injector for autoimmune drug
NCT ID NCT06293365
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests if a new 2mL auto-injector or pre-filled syringe delivers the same amount of the drug ianalumab into the body as the current 1mL syringe. About 155 adults with rheumatoid arthritis, Sjögren's disease, or lupus will receive the drug both ways to compare how much gets absorbed. The goal is to see if the larger device works just as well, which could mean fewer injections for patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ianalumab
- What this could lead to
- If successful, this could make it easier for patients to receive their medication with fewer injections, improving convenience and comfort.
- What could go wrong
- This is a small, early-phase study focused on drug levels, not on whether the drug itself works for the disease. The results may not change treatment or guarantee better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advanced Medical Research
La Palma, California, 90623, United States
-
Advanced Rheumatology of Houston
Spring, Texas, 77382, United States
-
Ahmed Arif Medical Research Center
Grand Blanc, Michigan, 48439, United States
-
Altoona Center for Clin Res
Duncansville, Pennsylvania, 16635, United States
-
Conquest Research
Winter Park, Florida, 32789, United States
-
Indiana Univ School of Dentistry
Indianapolis, Indiana, 46202, United States
-
Novartis Investigative Site
Quilmes, Buenos Aires, 1878, Argentina
-
Novartis Investigative Site
San Miguel Tucuman, Tucumán Province, T4000DPK, Argentina
-
Novartis Investigative Site
Buenos Aires, 1646, Argentina
-
Novartis Investigative Site
Buenos Aires, C1055AAF, Argentina
-
Novartis Investigative Site
Hamilton, Ontario, L8N 3Z5, Canada
-
Novartis Investigative Site
Toronto, Ontario, M5T 2S8, Canada
-
Novartis Investigative Site
Rimouski, Quebec, G5L 5T1, Canada
-
Novartis Investigative Site
Trois-Rivières, Quebec, G9A 3Y2, Canada
-
Novartis Investigative Site
Brno, 638 00, Czechia
-
Novartis Investigative Site
Prague, 128 00, Czechia
-
Novartis Investigative Site
Uherské Hradiště, 686 01, Czechia
-
Novartis Investigative Site
Debrecen, Hajdu Bihar Megye, 4032, Hungary
-
Novartis Investigative Site
Budapest, 1027, Hungary
-
Novartis Investigative Site
Budapest, 1134, Hungary
-
Novartis Investigative Site
Salerno, SA, 84131, Italy
-
Novartis Investigative Site
Krakow, 30-002, Poland
-
Novartis Investigative Site
Lublin, 20-607, Poland
-
Novartis Investigative Site
Santiago Compostela, A Coruna, 15706, Spain
-
Novartis Investigative Site
A Coruña, 15006, Spain
-
Novartis Investigative Site
Madrid, 28034, Spain
-
Novel Research LLC
Bellaire, Texas, 77401, United States
-
Ochsner Health System
Baton Rouge, Louisiana, 70809, United States
-
Paramount Med Rsrch and Consult LLC
Middleburg Heights, Ohio, 44130, United States
-
Parris and Associates Rheumatology
Lawrenceville, Georgia, 30044, United States
-
Pinnacle Research Group Llc
Anniston, Alabama, 36207, United States
-
Providence Medical Foundation
Fullerton, California, 92835, United States
-
RAO Research LLC
Oklahoma City, Oklahoma, 73116, United States
-
Shelby Research LLC
Memphis, Tennessee, 38119, United States
-
Southwest Rheum Rsrch LLC
Mesquite, Texas, 75150, United States
-
Uni of Texas Health Science Center
San Antonio, Texas, 78229, United States
-
West Tennessee Research Institute
Jackson, Tennessee, 38305, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new shoulder implant restore Pain-Free movement?
- Can a less invasive hip surgery speed up recovery?
- Which hip implant lasts longer? a Head-to-Head trial aims to find out
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers
- Can group learning make biotherapy safer for arthritis patients?
- Can a new biologic tame lupus flares?